NanoBio scientists find way to kill highly resistant bacteria

Many people are scared of germs and bacteria. Even more fear the super bugs that are resistant if not downright hostile to antibiotics. Ann Arbor-based NanoBio has found a way kill at least some of these bacteria.

Scientists at the University of Michigan spin-off have developed a topical nanoemulsion that kills the highly resistant strains of bacteria that cause chronic illness and death to people who suffer from cystic fibrosis. The hope is this new technique will help prevent pulmonary failure in patients and ultimately save lives.

NanoBio employs about 20 people and three interns, including seven ex-Pfizer employees. It hopes to hire another dozen people or so in the near future.

It has taken in tens of millions of dollars in venture capital to follow-through on the clinical trails for the drugs it is developing. It expects to start licensing these products this year.

Source: John Coffey, vice president of business development for NanoBio
Writer: Jon Zemke